Copyright © 2002 by the European Society of Cardiology.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Editorials
Is measuring endothelial function a good idea for prediction of coronary heart disease complications?
Department of Internal Medicine IICardiology, University of Ulm Medical Center, Ulm, Germany
References
- Rubanyi GM. The role of endothelium in cardiovascular homeostasis and diseases. J Cardiovasc Pharmacol. 1993;22:S1S14
- Ross R. Atherosclerosisan inflammatory disease. N Engl J Med. 1999;340:115126
[Free Full Text] - Luster AD. Chemokineschemotactic cytokines that mediate inflammation. N Engl J Med. 1998;338:436445
[Free Full Text] - Vita JA, Treasure CB, Nabel EG. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation. 1990;81:491497
[Abstract/Free Full Text] - Al Suwaidi J, Hamasaki S, Higano ST, Nishimura RA, Holmes DR, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation. 2000;101:948954
[Abstract/Free Full Text] - Schächinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation. 2000;101:18991906
[Abstract/Free Full Text] - Li H, Forstermann U. Nitric oxide in the pathogenesis of vascular disease. Am J Pathol. 2000;190:244254
- Whincup PH, Danesh J, Walker M. Von Willebrand factor and coronary heart disease: prospective study and meta-analysis. Eur Heart J. 2002;23:17641770
[Abstract/Free Full Text] - Pottinger BE, Read RC, Paleolog EM, Higgins PG, Pearson JD. Von Willebrand factor is an acute phase reactant in man. Throm Res. 1989;53:387394[CrossRef][ISI][Medline]
- Mannucci PM. Von Willebrand factor: a marker of endothelial damage? Arterioscler Thromb Vasc Biol. 1998;18:13591362
[Free Full Text] - Blann AD, Taberner DA. A reliable marker of endothelial cell dysfunction: does it exist? Br J Haematol. 1995;90:234241
- Jager A, van Hinsbergh VWM, Kostense PJ. Von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects. The Hoorn Study. Arterioscler Thromb Vasc Biol. 1999;19:30713078
[Abstract/Free Full Text] - Montalescot G, Philippe F, Ankri A. Early increase of von Willebrand factor predicts adverse outcome in unstable coronary artery disease: beneficial effects of enoxaparin. Circulation. 1998;98:287289
[Free Full Text] - Montalescot G, Collet JP, Lison L. Effects of various anticoagulant treatments on von Willebrand factor release in unstable angina. J Am Coll Cardiol. 2000;36:110114
[Abstract/Free Full Text] - Malik I, Danesh J, Whincup P. Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis. Lancet. 2001;358:971975[CrossRef][ISI][Medline]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||